N Usha's Insider Trades & SAST Disclosures
N Usha's most recent trade in Zydus Lifesciences Ltd. was a Disposal of 1,626 Equity Shares done at an average price of Rs. 1005 . Disclosure was reported to the exchange on March 18, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for N Usha in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | Usharani Ganesh Nayak | Directors Immediate Relative | Disposal | 18 Mar 2024 | 1,626 | 101,837 (0.01%) | 0.00% | 1005 | 1,634,130 | 14 Mar 2024 14 Mar 2024 |
Insider Trading | Equity Shares | Buy Back |
| Zydus Lifesciences | Usharani Ganesh Nayak | Directors Immediate Relative | Disposal | 27 Jul 2022 | 1,657 | 103,463 (0.01%) | 0.00% | 650 | 1,077,050 | 15 Jul 2022 15 Jul 2022 |
Insider Trading | Equity Shares | Buy Back |
| Zydus Lifesciences | Usharani Ganesh Nayak | Directors Immediate Relative | Disposal | 19 Jul 2022 | 1,657 | 103,463 (0.01%) | 0.00% | 0 | 0 | 15 Jul 2022 15 Jul 2022 |
Insider Trading | Equity Shares | Buy Back |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.